This site is intended for healthcare professionals only
LoginRegister
Strides, Orbicular ink pact to develop range of nasal spraysStrides, Orbicular ink pact to develop range of nasal sprays
Local CT waiver will be considered after submission of BE study result: CDSCO panel tells Synokem on RelugolixLocal CT waiver will be considered after submission of BE study result: CDSCO panel tells Synokem...
Laurus Labs bags USFDA nod for Paediatric ARV Oral Dispersible Film drug Dolutegravir in HIV/AIDS treatmentLaurus Labs bags USFDA nod for Paediatric ARV Oral Dispersible Film drug Dolutegravir in HIV/AIDS...
Gilead Sciences gets USFDA nod for new Biktarvy indicationGilead Sciences, US square off in billion-dollar HIV drug patent trial
CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III StudyUSFDA halts Sun Pharma trials on dermatological drug Deuruxolitinib
Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger PartnerPfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in...
Stryker opens new facility in BengaluruStryker raises profit forecast on stronger demand for surgical devices
Bharat Biotechs intranasal Covid vaccine iNCoVACC gets CDSCO Panel nod for PMS studyBharat Biotech's intranasal Covid vaccine iNCoVACC gets CDSCO Panel nod for PMS study
Bristol Myers Squibb gets USFDA priority review for expanded Reblozyl useBristol Myers Squibb gets USFDA priority review for expanded Reblozyl use
BioNTech , Pfizer propose EU pays half for each cancelled COVID dose: ReportBioNTech , Pfizer propose EU pays half for each cancelled COVID dose: Report
Abbotts Phensedyl Supply Chain Under Scanner After Ghaziabad Seizure, Codeine Diversion Probe WidensAbbott concludes acquisition of Cardiovascular Systems
Cancer MedTech Gets Clarity: CDSCO Releases Final Oncology Device Risk Classification List59 companies get land in upcoming medical device park near Noida
X